News

08 Nov 2017

REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services

Press release: REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services
Read More >>

08 Nov 2017

Visit REPROCELL at the “North East England Life Science Showcase” in Cambridge, MA (USA) on November 30, 2017

Visit REPROCELL at the “North East England Life Science Showcase” in Cambridge, MA (USA) on November 30, 2017
Read More >>

07 Nov 2017

Prof Stefan Przyborski to chair and speak at SMi Group’s 3D Cell Culture 2018 Conference

REPROCELL Europe Ltd's CSO Prof Stefan Przyborski to chair and speak at SMi Group’s 3D Cell Culture 2018 Conference
Read More >>

27 Sep 2017

Article by Dr David Bunton (co-authored) in the European Pharmaceutical Review, Autumn 2017

REPROCELL Europe Ltd’s CEO, Dr David Bunton, has co-authored an article titled New Strategy that has been published in the European Pharmaceutical Review, Autumn 2017. The article is in the EPR’s section, Applied Research, Development and Production. It is co-authored by David Bunton at REPROCELL Europe, Marian McNeil at Stratified Medicine Scotland and Pamela Brankin at Aridhia.
Read More >>

1 2 3 4 >>

Prof Stefan Przyborski to chair and speak at SMi Group’s 3D Cell Culture 2018 Conference

07/11/2017

Professor Stefan Przyborski, CSO REPROCELL Europe Ltd, will be giving a lecture at the SMi Group’s 3D Cell Culture 2018. The conference will be held on 21st-22nd February 2018 in London, UK.

 

Stefan is also Professor of Cell Technology at Durham University, UK and chairman of the 3D Cell Culture 2018 conference. Immediately after his conference opening remarks at the start of the conference, he will be giving his lecture titled, 3D Cell Culture – A Rapidly Developing Series of Technologies Enabling the Evolution of Complex Models of Human Tissues and In Vitro Assays.

 

The lecture will cover the following subjects:

 

• 3D vs 2D cell culture – the similarities and differences between both methods;

• Demand for 3D cell culture;

• No one solution – alternative techniques: organoids, spheroids, hydrogels and scaffolds;

• Examples of current applications – simple 3D cultures to engineering complex tissues;

• Case example – building layered tissue structures to model the anatomy and physiology of native counterparts;

• New developments in 3D cell culture and related technologies

 

Prof Przyborski has given an exclusive interview with SMi, which is available for download here (requires sign-up registration with SMi).

Live chat by BoldChat